Sutent 12.5 mg
Sutent 12.5 mg is a medicine authorised by Swissmedic under authorisation number 57563. The authorisation holder is Pfizer AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 28 April 2006 and the authorisation is valid without a time limit. ATC code L01EX01 places the medicine in the group Antineoplastic agents.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Sutent 12.5 mg, Hartkapseln | A | 28 April 2006 |
| 2 | Sutent 25 mg, Hartkapseln | A | 28 April 2006 |
| 3 | Sutent 50 mg, Hartkapseln | A | 28 April 2006 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 4 | 28 | Kapsel(n) | L01EX01 | 07.16.1. | A |
| 5 | 28 | Kapsel(n) | L01EX01 | 07.16.1. | A |
| 6 | 28 | Kapsel(n) | L01EX01 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Sutent 12.5 mg authorised in Switzerland?
Yes. Sutent 12.5 mg is authorised by Swissmedic under authorisation number 57563, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Sutent 12.5 mg have?
Sutent 12.5 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Sutent 12.5 mg?
The authorisation holder is Pfizer AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.